Please log in to determine if you are eligible to purchase PT Programs.
MULTIGENE TUMOR PANEL - MTP
MTP
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte Challenges per Shipment Number of Shipments
BRAF 3 Two shipments per year
EGFR 3
ERBB2 (HER2) 3
KIT 3
KRAS 3
NRAS 3
PDGFRA 3
PIK3CA 3

CAP accredited laboratories that perform testing for the detection of somatic single nucleotide variants, insertions, and deletions in BRAF, EGFR, and KRAS by non-NGS methods are required to enroll in either MTP or the respective single gene programs. This includes laboratories that perform non-NGS-based multiplexed assays, and nonmultiplexed assays (eg, Sanger sequencing). Laboratories that perform NGS-based testing of somatic single nucleotide variants, insertions, and deletions in BRAF, KRAS, EGFR, and/or other genes are required to enroll in NGSST.

Program Information

  • Three 2.0‑μg gDNA (50ng/‑μL) specimens for laboratories performing molecular testing on multiple targets

Shipping Schedule

  • Shipment A: February 12
  • Shipment B: August 19






Customers Who Bought This Item Also Bought
CELL-FREE TUMOR DNA
VIEW DETAILS >